The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-(Biphenyl-4-ylsulfonamido)-2-hydroxybenzoic Acid ID: ALA3360262
PubChem CID: 118724175
Max Phase: Preclinical
Molecular Formula: C19H15NO5S
Molecular Weight: 369.40
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)c1cc(NS(=O)(=O)c2ccc(-c3ccccc3)cc2)ccc1O
Standard InChI: InChI=1S/C19H15NO5S/c21-18-11-8-15(12-17(18)19(22)23)20-26(24,25)16-9-6-14(7-10-16)13-4-2-1-3-5-13/h1-12,20-21H,(H,22,23)
Standard InChI Key: ZHUKUTFVXZFATC-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
3.6402 -1.1804 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.0529 -1.8903 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.4614 -1.1779 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.3472 -2.3030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7626 -2.3030 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.4703 -1.8944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6373 -1.8952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9320 -2.3073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9362 -3.1257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6514 -3.5304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3538 -3.1160 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1767 -2.3074 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8839 -1.8995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8844 -1.0814 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1717 -0.6730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4674 -1.0833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2345 -3.5378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5237 -3.1324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1825 -3.5452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1795 -4.3633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5400 -4.7668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2415 -4.3517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5915 -0.6719 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.5923 -2.3091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5919 -3.1263 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.3002 -1.9009 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 2 1 0
2 5 1 0
5 6 1 0
4 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 4 1 0
6 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 6 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
9 17 1 0
14 23 1 0
24 25 1 0
24 26 2 0
13 24 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 369.40Molecular Weight (Monoisotopic): 369.0671AlogP: 3.56#Rotatable Bonds: 5Polar Surface Area: 103.70Molecular Species: ACIDHBA: 4HBD: 3#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 2.66CX Basic pKa: ┄CX LogP: 4.11CX LogD: 0.54Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.60Np Likeness Score: -0.94
References 1. Jung HJ, Cho M, Kim Y, Han G, Kwon HJ.. (2014) Development of a novel class of mitochondrial ubiquinol-cytochrome c reductase binding protein (UQCRB) modulators as promising antiangiogenic leads., 57 (19): [PMID:25244355 ] [10.1021/jm500863j ]